tetano
Editor, Senior Moderator
Arch Neurol. 2011 Oct;68(10):1327-9.
Postvaccination miller fisher syndrome.
Shoamanesh A, Chapman K, Traboulsee A.
Source
Department of Medicine and Neurology, University of British Columbia, 1103-1068 W Broadway Ave, Vancouver, BC V6H 0A7, Canada. ashkan.sho@gmail.com.
Abstract
BACKGROUND:
Although postvaccination Guillain-Barr? syndrome is commonly reported, there have only been 2 previously reported cases of postvaccination Miller Fisher syndrome, and none in association with the novel influenza A(H1N1) vaccine.
OBJECTIVE:
To describe a case of Miller Fisher syndrome following receipt of the seasonal influenza and novel influenza A(H1N1) vaccine.
DESIGN:
Case report and literature review.
SETTING:
Vancouver General Hospital. Patient A 77-year-old Chinese woman.
RESULTS:
The patient presented with ophthalmoplegia, ataxia, areflexia, and a sensory neuropathy within 2 weeks of immunization. Findings of parainfectious evaluation were unremarkable. Treatment with 2 courses of intravenous immunoglobulin led to clinical improvement. Her presentation and natural history of disease were similar to the 2 previously published cases.
CONCLUSIONS:
We present the third case of postvaccination Miller Fisher syndrome in the literature and the first associated with the novel influenza A(H1N1) vaccine.
PMID:
21987549
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/21987549
Postvaccination miller fisher syndrome.
Shoamanesh A, Chapman K, Traboulsee A.
Source
Department of Medicine and Neurology, University of British Columbia, 1103-1068 W Broadway Ave, Vancouver, BC V6H 0A7, Canada. ashkan.sho@gmail.com.
Abstract
BACKGROUND:
Although postvaccination Guillain-Barr? syndrome is commonly reported, there have only been 2 previously reported cases of postvaccination Miller Fisher syndrome, and none in association with the novel influenza A(H1N1) vaccine.
OBJECTIVE:
To describe a case of Miller Fisher syndrome following receipt of the seasonal influenza and novel influenza A(H1N1) vaccine.
DESIGN:
Case report and literature review.
SETTING:
Vancouver General Hospital. Patient A 77-year-old Chinese woman.
RESULTS:
The patient presented with ophthalmoplegia, ataxia, areflexia, and a sensory neuropathy within 2 weeks of immunization. Findings of parainfectious evaluation were unremarkable. Treatment with 2 courses of intravenous immunoglobulin led to clinical improvement. Her presentation and natural history of disease were similar to the 2 previously published cases.
CONCLUSIONS:
We present the third case of postvaccination Miller Fisher syndrome in the literature and the first associated with the novel influenza A(H1N1) vaccine.
PMID:
21987549
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/21987549